uvadex 20 mikrogramów/ml roztwór do frakcjonowania krwi 20 mcg/ml roztwór do modyfikowania frakcji krwi
therakos europe ltd - methoxsalenum - roztwór do modyfikowania frakcji krwi - 20 mcg/ml
amisulpryd holsten 200 mg tabletki
holsten pharma gmbh - amisulpridum - tabletki - 200 mg
amisulpryd holsten 400 mg tabletki powlekane
holsten pharma gmbh - amisulpridum - tabletki powlekane - 400 mg
amsulgen 100 mg tabletki
generics [uk] limited - amisulpridum - tabletki - 100 mg
aposuprid 200 mg tabletki
aurovitas pharma polska sp. z o.o. - amisulpridum - tabletki - 200 mg
aposuprid 400 mg tabletki powlekane
aurovitas pharma polska sp. z o.o. - amisulpridum - tabletki powlekane - 400 mg
apodream 7,5 mg tabletki powlekane
aurovitas pharma polska sp. z o.o. - zopiclonum - tabletki powlekane - 7,5 mg
sarclisa
sanofi winthrop industrie - isatuximab - szpiczak mnogi - Środki przeciwnowotworowe - sarclisa is indicated: in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi) and have demonstrated disease progression on the last therapy. in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy (see section 5.